Skip to main content
Premium Trial:

Request an Annual Quote

Horizon Discovery CRISPR Screening Service for Primary Human T Cells

Horizon Discovery has extended its CRISPR Screening Service to include ex vivo T lymphocytes. Horizon has adapted its established CRISPRko (knockout) platform to screen human T lymphocytes, adding CRISPRko screens in ex vivo T lymphocytes to its established CRISPR screening formats – CRISPRko, CRISPRi (interference) and CRISPRa (activation) – in cancer cell lines. The service extension meets the requirements of immunology-based research in drug discovery, allowing for the identification of new gene targets in biologically and potentially therapeutically relevant settings, the firm said.

The Scan

Vaccine Update Recommended

A US Food and Drug Administration panel recommends booster vaccines be updated to target Omicron, CNBC reports.

US to Make More Vaccines for Monkeypox Available

The US is to make nearly 300,000 vaccine doses available in the coming weeks to stem the spread of human monkeypox virus, according to NPR.

Sentence Appealed

The Associated Press reports that Swedish prosecutors are appealing the sentence given to a surgeon once lauded for transplanting synthetic tracheas but then convicted of causing bodily harm.

Genome Biology Papers on COVID-19 Effector Genes, Virtual ChIP-seq, scDART

In Genome Biology this week: proposed COVID-19 effector genes, method to predict transcription factor binding patterns, and more.